G1 Therapeutics, Inc.
NASDAQ:GTHX
7.16 (USD) • At close September 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -47.967 | -147.559 | -148.352 | -99.254 | -122.447 | -85.288 | -60.121 | -30.291 | -20.263 | -6.678 |
| Depreciation & Amortization
| 0.513 | 0.53 | 0.469 | 0.582 | 0.356 | 0.175 | 0.089 | 0.067 | 0.042 | 0.017 |
| Deferred Income Tax
| 1.228 | 0 | 0.59 | -0.545 | -16.913 | 0 | 0 | -1.372 | 4.86 | -0.279 |
| Stock Based Compensation
| 14.51 | 20.589 | 22.319 | 18.77 | 16.449 | 10.225 | 3.394 | 1.391 | 0.389 | 0.074 |
| Change In Working Capital
| -5.203 | -5.307 | -8.838 | -4.076 | 6.071 | 0.573 | 6.072 | 3.592 | 0.946 | 0.208 |
| Accounts Receivables
| -1.593 | -5.406 | -5.451 | -0.237 | 0 | 0 | 0 | 0 | 0 | 0.205 |
| Inventory
| 3.737 | -12.708 | -3.471 | -3.832 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -3.372 | 4.421 | -0.675 | -0.244 | 0.248 | -1.002 | 6.325 | 0 | 0 | 0 |
| Other Working Capital
| -3.975 | 8.386 | 0.759 | 0.237 | 5.823 | 1.575 | -0.253 | 3.592 | 0.946 | 0.003 |
| Other Non Cash Items
| -1.418 | 3.127 | 1.704 | 0.781 | 16.913 | 0.008 | 0.047 | 1.473 | 0.181 | -0.118 |
| Operating Cash Flow
| -38.337 | -128.62 | -132.108 | -83.742 | -99.571 | -74.307 | -50.519 | -25.141 | -13.845 | -6.498 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| 0 | -0.506 | 0 | 0 | -2.716 | -0.709 | -0.294 | -0.25 | -0.087 | -0.103 |
| Acquisitions Net
| 0 | 50.023 | 0 | 0.152 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -124.69 | -65.023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 127.5 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 2.81 | -50.023 | 0 | 0.152 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 2.81 | -50.529 | 0 | 0.152 | -2.716 | -0.709 | -0.294 | -0.25 | -0.087 | -0.103 |
| Financing Activities: | ||||||||||
| Debt Repayment
| -26.688 | 0 | 55 | 20 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| -0.224 | 52.383 | 86.429 | 2.308 | 2.705 | 339.589 | 108.503 | 50.007 | 33.315 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.249 | -0.139 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.224 | 0.112 | 4.434 | 1.688 | 2.705 | 0.905 | -1.183 | 49.758 | 33.176 | 6.271 |
| Financing Cash Flow
| -26.912 | 52.495 | 145.863 | 21.688 | 2.705 | 340.494 | 107.32 | 49.758 | 33.176 | 6.271 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 0.063 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.024 |
| Net Change In Cash
| -62.376 | -126.654 | 13.755 | -61.902 | -99.582 | 265.478 | 56.507 | 24.367 | 19.244 | 3.694 |
| Cash At End Of Period
| 32.281 | 94.907 | 221.561 | 207.806 | 269.708 | 369.29 | 103.812 | 47.305 | 22.938 | 3.694 |